April 17, 2026 7:46 AM
Latest:
  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness
  • Equinox Ups Its Offer For Calibre: Investors Said No!
  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
  • Agnico Eagle Q1 Earnings: Costs Go Down?!
The Deep Dive

the deep dive

Providing stock analysis for investors of the Canadian junior markets

  • Home
  • Latest
    • Automotive
    • Cannabis
    • Commentary
    • Full Analysis
    • Gold
    • Industrials
    • Macro
    • Oil
    • Resources
    • Technology
  • Resources
  • Energy
  • Technology
  • Coverage Companies
    • Brazil Potash
    • Canadian Copper
    • Cardiol Therapeutics
    • Cytophage Technologies
    • ESGold Corp
    • First Majestic Silver
    • Golden Cariboo Resources
    • Nations Royalty Corp
    • Plurilock Security
    • Power Metallic
    • PTX Metals
    • Riverside Resources
    • Rua Gold
    • Silver47 Exploration
    • Sonoro Gold
    • Spirit Blockchain
    • Temas Resources
  • Verses AI
  • About
  • Contact Us

CloudMD

Healthcare Latest 

CloudMD Closes On $60 Million Acquisition Of VisionPros

June 24, 2021 8:14 AMJune 24, 2021 8:14 AM Jay Lutz 0 Comments CloudMD

CloudMD Software & Services (TSXV: DOC) this morning announced the closing of the acquisition of VisionPros in a transaction pegged

Share
Tweet
Share
Reddit
Read more
Healthcare Latest 

CloudMD: Canaccord Lowers Revenue Estimates, Maintains Ratings

May 31, 2021 10:31 AMMay 31, 2021 9:40 AM Justin Young 0 Comments Analyst Estimate, CloudMD

On May 28th, CloudMD Software & Services Inc. (TSXV: DOC) reported its first-quarter financial results. The company announced revenue of

Share
Tweet
Share
Reddit
Read more
Healthcare Latest 

CloudMD Posts $8.8 Million In Revenue, $5.3 Million Net Loss For Q1 2021

May 28, 2021 9:29 AMMay 28, 2021 9:21 AM ER Velasco 0 Comments CloudMD

CloudMD Software & Services Inc. (TSXV: DOC) last night released its Q1 2021 financial results, which saw the company post

Share
Tweet
Share
Reddit
Read more
Healthcare Latest 

CloudMD To Acquire Oncidium For $100 Million

April 8, 2021 8:52 AMApril 8, 2021 8:53 AM Jay Lutz 0 Comments CloudMD

CloudMD Software & Services (TSXV: DOC) this morning announced its largest acquisition to date. The company will be acquiring that

Share
Tweet
Share
Reddit
Read more
Healthcare Latest 

CloudMD: Canaccord Lowers Target After Leading $55 Million Bought Deal

March 16, 2021 4:08 PMMarch 16, 2021 9:09 AM Justin Young 0 Comments Analyst Estimate, CloudMD

On March 9th, CloudMD Software & Services (TSXV: DOC)  announced that their C$55 million bought deal financing closed, with underwriters

Share
Tweet
Share
Reddit
Read more
Healthcare Latest Technology 

CloudMD: Canaccord Raises Price Target To $3.75

February 19, 2021 4:01 PMFebruary 18, 2021 11:27 PM Justin Young 1 Comment Analyst Estimate, CloudMD

Wednesday morning, it was announced that CloudMD Software & Services (TSXV: DOC) is acquiring VisionPros, a vertically integrated eyecare platform.

Share
Tweet
Share
Reddit
Read more
Healthcare Latest Technology 

CloudMD: Canaccord Reiterates $3.25 Price Target Following Acquisition

January 27, 2021 4:01 PMJanuary 27, 2021 2:22 PM Justin Young 0 Comments Analyst Estimate, CloudMD

This morning, CloudMD Software & Services (TSXV: DOC) announced that they purchased Rx Infinity, an e-commerce specialty pharmacy, and wholesaler,

Share
Tweet
Share
Reddit
Read more
Latest Technology 

CloudMD Expands Partnership With Save-On-Foods For Telemedicine

December 7, 2020 9:10 AMDecember 7, 2020 9:11 AM Jay Lutz 0 Comments CloudMD

CloudMD Software & Services (TSXV: DOC) is expanding its pilot telemedicine program with that of Save-On-Foods. The grocer, which has

Share
Tweet
Share
Reddit
Read more
Latest Technology 

Canaccord: CloudMD’s Third Quarter Results Were “In The Range Of Expectations”

December 1, 2020 3:41 PMDecember 1, 2020 2:12 PM Justin Young 0 Comments Analyst Estimate, CloudMD

On November 30th, CloudMD Software & Services (TSXV: DOC) reported its third-quarter financial results. CloudMD reported record revenue of $3.4

Share
Tweet
Share
Reddit
Read more
Latest Technology 

CloudMD: Canaccord Remains Bullish Following Virtual Conference

November 25, 2020 11:11 AMNovember 25, 2020 10:12 AM Justin Young 0 Comments Analyst Estimate, CloudMD, Telehealth

Recently, CloudMD Software & Services (TSXV: DOC)‘s CEO Essam Hamza participated in Canaccord Genuity’s Health & Wellness Virtual Conference. Doug

Share
Tweet
Share
Reddit
Read more
  • ← Previous
  • Next →

Latest

  • Teck Resources Q1 Earnings: Defying Copper Industry Weakness

  • Equinox Ups Its Offer For Calibre: Investors Said No!

  • First Quantum Q1 Earnings: Copper Major Still Bleeding Cash

  • Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win

  • Agnico Eagle Q1 Earnings: Costs Go Down?!

  • Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman

  • Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.

  • Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Full Analysis Latest Resources Video Series 

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

Trending

  • Missouri Cannabis Sales Rake in $240 Million in New Tax Revenue Over Past Year
  • Canada Is Nearly Last In Growth Among OECD Countries
  • Curaleaf Sees CFO Ranjan Kalia Leave Company After Eight Months On The Job
  • Nvidia Slumps Before Rebounding Following Fiscal Q2 2023 Earnings Release Marred With Declining Income And Weaker Guidance
  • Trudeau’s Decision to Sell Canada’s Gold Reserves Has Now Cost Canada Over $149 million

News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial
Biotech Latest News 

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek
Latest News Resources 

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0
Canadian Copper To Begin Exploration At Murray Brook East
Latest News Resources 

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Menu

  • Home
  • About
  • Research
  • Discover
  • Contact Us
  • Disclaimer

Categories

  • Automotive
  • Biotech
  • Bonds
  • Cannabis
  • Commentary
  • Crypto
  • Education
  • Energy
  • Entertainment
  • Esports
  • ETFs
  • Food
  • Full Analysis
  • Healthcare
  • Industrials
  • Latest
  • Lithium
  • Macro
  • Market Movers
  • Mental Hurdles
  • News
  • Oil
  • Politics
  • Psychedelics
  • Real Estate
  • Resources
  • Retail
  • SPACs
  • Technology
  • Video Series
Copyright © 2026 the deep dive. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.